Similar to cytokine release syndrome (CRS) after adoptive T cell therapy, ICIs may lead to hyper-physiological levels of proinflammatory cytokines, especially IL-6, resulting in irAEs. This evidence concerns the gene IL6 and congenital rubella syndrome.